X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (25858) 25858
Publication (4120) 4120
Book Review (544) 544
Book Chapter (213) 213
Conference Proceeding (62) 62
Dissertation (11) 11
Data Set (4) 4
Magazine Article (3) 3
Reference (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16640) 16640
index medicus (12070) 12070
animals (9502) 9502
immunodeficiency-virus type-1 (5660) 5660
immunology (5076) 5076
type-1 (4948) 4948
virology (4647) 4647
female (4607) 4607
male (4413) 4413
hiv (4269) 4269
mice (3834) 3834
biochemistry & molecular biology (3826) 3826
human-immunodeficiency-virus (2922) 2922
research (2817) 2817
cell biology (2767) 2767
viruses (2752) 2752
infectious diseases (2652) 2652
expression (2608) 2608
infection (2605) 2605
health aspects (2493) 2493
adult (2380) 2380
cell line (2323) 2323
proteins (2314) 2314
article (2275) 2275
molecular sequence data (2173) 2173
analysis (2116) 2116
hiv-1 (2091) 2091
cells, cultured (2030) 2030
microbiology (1964) 1964
hiv-1 - physiology (1945) 1945
virus diseases (1938) 1938
hiv infections - immunology (1936) 1936
pharmacology & pharmacy (1899) 1899
amino acid sequence (1890) 1890
middle aged (1881) 1881
hiv-1 - genetics (1879) 1879
hiv infections - virology (1828) 1828
research article (1794) 1794
hiv-1 - immunology (1785) 1785
multidisciplinary sciences (1690) 1690
endocrinology & metabolism (1682) 1682
physiological aspects (1637) 1637
rats (1633) 1633
human immunodeficiency virus--hiv (1614) 1614
aids (1583) 1583
medicine, research & experimental (1565) 1565
in-vivo (1503) 1503
mutation (1500) 1500
gene expression (1497) 1497
genetic aspects (1484) 1484
infections (1476) 1476
neurosciences (1466) 1466
cells (1458) 1458
medicine (1431) 1431
receptor (1429) 1429
activation (1334) 1334
hiv infection (1327) 1327
in-vitro (1322) 1322
biology (1313) 1313
t cells (1283) 1283
disease progression (1253) 1253
human immunodeficiency virus (1199) 1199
t-cells (1199) 1199
protein binding (1194) 1194
protein (1190) 1190
lymphocytes (1185) 1185
gene-expression (1173) 1173
replication (1157) 1157
oncology (1156) 1156
type-1 infection (1108) 1108
signal transduction (1104) 1104
apoptosis (1063) 1063
dendritic cells (1055) 1055
hiv-1 - drug effects (1042) 1042
virus replication (1027) 1027
ii type-1 receptor (1006) 1006
inflammation (1003) 1003
binding (994) 994
science (989) 989
genetics & heredity (987) 987
aged (984) 984
antibodies (983) 983
risk factors (969) 969
hiv-1 - metabolism (951) 951
cancer (936) 936
mice, inbred c57bl (915) 915
disease models, animal (909) 909
hiv infections - drug therapy (909) 909
binding sites (887) 887
cytokines (872) 872
type-1 receptor (858) 858
antiviral agents (846) 846
disease (843) 843
cd4-positive t-lymphocytes - immunology (840) 840
development and progression (826) 826
care and treatment (825) 825
acquired immune deficiency syndrome--aids (816) 816
envelope glycoprotein (813) 813
base sequence (812) 812
flow cytometry (811) 811
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25786) 25786
French (55) 55
German (30) 30
Spanish (30) 30
Polish (13) 13
Russian (13) 13
Japanese (10) 10
Portuguese (5) 5
Hungarian (3) 3
Chinese (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Philosophical Transactions: Biological Sciences, ISSN 0962-8436, 12/2012, Volume 367, Issue 1607, pp. 3216 - 3228
The endocannabinoid system was revealed following the understanding of the mechanism of action of marijuana's major psychotropic principle,... 
Enzymes | Receptors | Cannabinoids | Neuroscience | Neurons | Agonists | Ligands | Biosynthesis | Endocannabinoids | Cannabinoid receptors | Transient receptor potential vanilloid type-1 | Cannabinoid receptor type-1 | Cannabinoid receptor type-2 | Endocannabinoid | Cannabinoid | Endovanilloid | endovanilloid | endocannabinoid | cannabinoid | transient receptor potential vanilloid type-1 | cannabinoid receptor type-1 | cannabinoid receptor type-2 | NERVE GROWTH-FACTOR | CB1 RECEPTOR | VANILLOID TYPE-1 RECEPTORS | ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL | CALCIUM-CHANNELS | ACID AMIDE HYDROLASE | LONG-TERM DEPRESSION | BIOLOGY | SMOOTH-MUSCLE-CELLS | PRIMARY SENSORY NEURONS | TRPV1 CHANNELS | Endocannabinoids - metabolism | Cannabinoid Receptor Agonists - metabolism | Endocannabinoids - pharmacology | Receptor, Cannabinoid, CB2 - agonists | Humans | Cannabinoid Receptor Agonists - pharmacology | Synaptic Transmission | Brain - metabolism | TRPV Cation Channels - metabolism | Arachidonic Acids - metabolism | Pain Perception - drug effects | Receptor, Cannabinoid, CB1 - agonists | TRPV Cation Channels - antagonists & inhibitors | Neuralgia - physiopathology | Receptor Cross-Talk | Signal Transduction | Glycerides - metabolism | Polyunsaturated Alkamides - metabolism | Arachidonic Acids - pharmacology | Neuralgia - drug therapy | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Glycerides - pharmacology | Animals | Polyunsaturated Alkamides - pharmacology | 133 | 202 | Review
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 12/2007, Volume 27, Issue 12, pp. 2532 - 2539
Angiotensin (Ang) II exerts its important physiological functions through 2 distinct receptor subtypes, type 1 (AT1) and type 2 (AT2) receptors. Recently, new... 
Angiotensin II receptor | Angiotensin II type-1 receptor blocker | Dimerization | Interacting protein | G protein' coupled receptor | G protein-coupled receptor | angiotensin II type-1 | AT RECEPTOR | SPONTANEOUSLY HYPERTENSIVE-RATS | dimerization | BRADYKININ B-2 RECEPTOR | PROTEIN-COUPLED RECEPTORS | TYPE-1 RECEPTOR | SMOOTH-MUSCLE CELL | interacting protein | GROWTH-FACTOR RECEPTOR | receptor blocker | PROXIMAL TUBULE CELLS | AGONISTIC ANTIBODIES | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | AT2 RECEPTOR | angiotensin II receptor | Antihypertensive Agents - pharmacology | Autoantibodies - metabolism | Receptor, Angiotensin, Type 2 - chemistry | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Hypertension - drug therapy | Angiotensin II Type 1 Receptor Blockers - pharmacology | Receptor, Angiotensin, Type 1 - chemistry | Multiprotein Complexes - metabolism | Kruppel-Like Transcription Factors - metabolism | Membrane Transport Proteins - metabolism | Receptor, Angiotensin, Type 1 - drug effects | Receptor, Angiotensin, Type 1 - immunology | Receptor, Angiotensin, Type 2 - agonists | Tumor Suppressor Proteins - metabolism | Angiotensin II - metabolism | Antihypertensive Agents - therapeutic use | Hypertension - metabolism | Animals | Receptor, Angiotensin, Type 2 - metabolism | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - metabolism | Signal Transduction - drug effects | Ubiquitin-Conjugating Enzymes - metabolism | Drug Inverse Agonism | Receptor, Angiotensin, Type 1 - metabolism | Ligands | Protein Conformation | Adaptor Proteins, Signal Transducing - metabolism | GTP-Binding Proteins - metabolism
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 02/2012, Volume 9, Issue 1, pp. 38 - 38
Background: Several recent studies have shown that angiotensin type 1 receptor (AT1) antagonists such as candesartan inhibit the microglial inflammatory... 
Neuroprotection | Peroxisome proliferator-activated receptor gamma | Angiotensin | Neuroinflammation | AT1 | Parkinson | Microglia | Telmisartan | NADPH OXIDASE | OXIDATIVE STRESS | telmisartan | PROLIFERATOR-ACTIVATED RECEPTORS | DOPAMINERGIC-NEURONS | NEUROSCIENCES | NAD(P)H OXIDASE | ANG-II TYPE-1 | TYPE-1-RECEPTOR ANTAGONISTS | neuroinflammation | neuroprotection | MITOCHONDRIAL DYSFUNCTION | SMOOTH-MUSCLE-CELLS | CENTRAL-NERVOUS-SYSTEM | microglia | peroxisome proliferator-activated receptor gamma | Encephalitis - prevention & control | Microglia - metabolism | Tyrosine 3-Monooxygenase - metabolism | Benzoates - therapeutic use | Leukocyte Common Antigens - metabolism | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Male | PPAR gamma - metabolism | Brain - metabolism | MPTP Poisoning - complications | Mass Spectrometry | Dopaminergic Neurons - drug effects | Cell Death - drug effects | Benzimidazoles - therapeutic use | Disease Models, Animal | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Microglia - drug effects | Gene Expression Regulation - genetics | Mice, Inbred C57BL | Encephalitis - pathology | Mice, Knockout | Brain - drug effects | Gene Expression Regulation - drug effects | Animals | PPAR gamma - antagonists & inhibitors | Analysis of Variance | Anilides - pharmacology | Brain - pathology | Lectins | Mice | MPTP Poisoning - chemically induced | Encephalitis - etiology | Receptor, Angiotensin, Type 1 - deficiency
Journal Article
Peptides, ISSN 0196-9781, 2007, Volume 28, Issue 9, pp. 1631 - 1639
Journal Article
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 09/2011, Volume 7, Issue 5, pp. 659 - 674
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 06/2013, Volume 169, Issue 3, pp. 477 - 492
Recent advances have improved our understanding of the renin‐angiotensin system (RAS). These have included the recognition that angiotensin (Ang)‐(1‐7) is a... 
angiotensin‐(1‐7) | renal diseases | fibrosis | Mas receptor | inflammation | angiotensin-(1-7) | CONVERTING ENZYME 2 | EXPERIMENTAL AUTOIMMUNE MYOCARDITIS | SPONTANEOUSLY HYPERTENSIVE-RATS | II TYPE-1 RECEPTOR | PROXIMAL TUBULAR CELLS | TRANSFORMING GROWTH FACTOR-BETA | END-ORGAN PROTECTION | INTERACTIONS IN-VIVO | INDUCED CARDIAC DYSFUNCTION | PHARMACOLOGY & PHARMACY | TGF-BETA ACTIVATION | Leukocytes - pathology | Kidney - pathology | Receptors, G-Protein-Coupled - metabolism | Humans | Kidney - immunology | Angiotensin I - therapeutic use | Nephritis - pathology | Receptors, G-Protein-Coupled - agonists | Leukocytes - immunology | Peptidyl-Dipeptidase A - genetics | Kidney - metabolism | Nephritis - immunology | Proto-Oncogene Proteins - agonists | Peptidyl-Dipeptidase A - metabolism | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Peptide Fragments - metabolism | Kidney - drug effects | Angiotensin I - metabolism | Animals | Peptidyl-Dipeptidase A - chemistry | Signal Transduction - drug effects | Models, Biological | Nephritis - therapy | Fibrosis | Receptors, G-Protein-Coupled - antagonists & inhibitors | Leukocytes - drug effects | Nephritis - metabolism | Cell Proliferation - drug effects | Peptide Fragments - therapeutic use | Leukocytes - metabolism | Inflammation | Angiotensin | Reviews
Journal Article
Trends in Cell Biology, ISSN 0962-8924, 2009, Volume 19, Issue 8, pp. 385 - 394
Journal Article